61417-04-7

N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide

N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide

Catalog No.1090339
Name N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide
CAS61417-04-7
FormulaC21H19N3O3S
Boiling Point306.4 ( ℃ )

Request a Quote

Structure of 61417-04-7

About N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide

N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide is a chemical compound registered under CAS number 61417-04-7, with the molecular formula C21H19N3O3S and a molecular weight of about 393.45 g/mol. KingPharm Group supplies N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide for laboratory research and bulk production; product code 1090339. Send an inquiry for purity, packaging, price and lead time.

CAS Number
61417-04-7
Molecular Formula
C21H19N3O3S
Molecular Weight
393.45 g/mol

Related Products

  1. Cyclohexanecarboxylic acid, 1-(3-ethoxy-2-propenyl)-2-oxo-, ethylester, (E)-
    87698-17-7
  2. 1,6-Hexanediol, ethoxy-
    89697-35-8
  3. 1,2,4-Trioxan-5-amine,6,6-dimethyl-3-(1-methylethyl)-N-1-naphthalenyl-, cis-
    89497-73-4
  4. Benzenebutanoic acid, a-cyano-2-nitro-b-oxo-, ethyl ester
    61417-34-3
  5. 2-Propenoic acid,2-methyl-3-[4-[[4-(2-quinolinylmethoxy)phenyl]thio]phenyl]-, methyl ester,(2E)-
    830328-31-9
  6. Morpholine,4-[[3,4-dihydro-1-oxo-3-(phenylmethyl)-1H-2-benzopyran-4-yl]carbonyl]-,cis-
    61418-31-3
  7. Magnesium,bis[[[1-(1-naphthalenyl)ethylidene]amino]-4-pyridinylmethyl]-
  8. 6 alpha-tigloyloxychaparrinone
  9. 2H-1,6-Benzothiazocine, 3,4,5,6-tetrahydro-5-(2-thienyl)-
  10. 1H-3-Benzazepin-1-ol,2,3,4,5-tetrahydro-7,8-dimethoxy-3-[(4-methylphenyl)sulfonyl]-2-(phenylmethyl)-, trans-
  11. 61417-04-7 msds
  12. CAS No 61417-04-7 supplier
  13. CASNo 61417-04-7 distributor
  14. CAS # 61417-04-7 manufacturer
  15. CAS Number 61417-04-7 safety
  16. CAS RN 61417-04-7 wholesale
  17. 2026-10-24 Find N-[4-(1-Methoxy-9-acridinylamino)phenyl]methanesulfonamide,CAS No.61417-04-7,Formula:C21H19N3O3S in KingPharm Group